Blood, antisera, vaccines, toxins and cultures in United States

2019
Exports | Imports
: $29.7B | $45.8B, World Rnk 4 / 201
Flag Rnk 8 / 1217 | World Rnk 1 / 222
Flag Rnk 8 / 1215

2019
Destination | Origin
: $3.58B | $13.1B, Germany | Ireland

2018 - 2019
FASTEST GROWING MARKET |  FASTEST GROWING ORIGIN
: $1.16B | $2.86B, China |  Belgium

2019
ECONOMIC COMPLEXITY of United States
: 1.64, Rnk 9 / 157

2019
PRODUCT COMPLEXITY  IN Blood, antisera, vaccines, toxins and cultures
: 1.19, Rnk 110 / 1029

Exports: In 2019, United States exported $29.7B in Blood, antisera, vaccines, toxins and cultures, making it the 4th largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 8th most exported product in United States. The main destination of Blood, antisera, vaccines, toxins and cultures exports from United States are: Germany ($3.58B), Netherlands ($3.21B), Switzerland ($2.42B), China ($2.31B), and Italy ($2.27B).

The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of United States between 2018 and 2019 were China ($1.16B), Germany ($751M), and Netherlands ($490M).

Imports: In 2019, United States imported $45.8B in Blood, antisera, vaccines, toxins and cultures, becoming the 1st largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 8th most imported product in United States. United States imports Blood, antisera, vaccines, toxins and cultures primarily from: Ireland ($13.1B), Switzerland ($9.13B), Belgium ($5.78B), Germany ($4.34B), and United Kingdom ($2.92B).

The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for United States between 2018 and 2019 were Belgium ($2.86B), Switzerland ($2.59B), and Germany ($1.03B).

Overview: In January 2021 United States' Blood, antisera, vaccines, toxins and cultures exports accounted up to $2.45B and imports accounted up to $5.91B, resulting in a negative trade balance of $3.46B. Between January 2020 and January 2021 the exports of United States'   Blood, antisera, vaccines, toxins and cultures have increased by $531M (27.6%) from $1.92B to $2.45B, while imports increased by $1.64B (38.4%) from $4.27B to $5.91B.

Destinations: In January 2021 Blood, antisera, vaccines, toxins and cultures exported mostly to China ($410M), Netherlands ($339M), Germany ($301M), Italy ($178M), and Switzerland ($143M), and imported mostly from Germany ($1.7B), Ireland ($1.58B), Belgium ($554M), Switzerland ($547M), and Japan ($305M).

Growth: In January 2021, the increase in Blood, antisera, vaccines, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to China ($363M or 783%), Netherlands ($103M or 43.8%), and Germany ($59.5M or 24.6%). In January 2021, the increase in Blood, antisera, vaccines, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from Germany ($592M or 53.2%), Ireland ($479M or 43.6%), and Switzerland ($341M or 166%).

Subnational Monthly Trade

#permalink to section
Flow
Value

EXPORT GROWTH (January 2020 - January 2021): $531M, (27.6%)

IMPORT GROWTH (January 2020 - January 2021): $1.64B, (38.4%)

MAIN EXPORTER (January 2021): North Carolina, $443M

MAIN DESTINATION (January 2021): China, $410M

This section shows Blood, antisera, vaccines, toxins and cultures's exports and imports data at subnational level for United States. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Blood, antisera, vaccines, toxins and cultures over time.

Value

EXPORTS (2019): $29.7B

IMPORTS (2019): $45.8B

NET TRADE (2019): -$16.1B

In 2019, United States exported $29.7B in Blood, antisera, vaccines, toxins and cultures. The main destinations of United States exports on Blood, antisera, vaccines, toxins and cultures were Germany ($3.58B), Netherlands ($3.21B), Switzerland ($2.42B), China ($2.31B), and Italy ($2.27B).

In 2019, United States imported $45.8B in Blood, antisera, vaccines, toxins and cultures, mainly from Ireland ($13.1B), Switzerland ($9.13B), Belgium ($5.78B), Germany ($4.34B), and United Kingdom ($2.92B).

Explore Visualizations

IN 2019, United States HAD A POSITIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

IN 2019, United States HAD A NEGATIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

Flow

THE FASTEST GROWING Blood, antisera, vaccines, toxins and cultures EXPORT MARKETS FOR United States WERE (2018 - 2019):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Blood, antisera, vaccines, toxins and cultures BY United States WERE (2018 - 2019):

Explore Visualizations

Market Concentration

#permalink to section
Flow
Type

In 2018, United States's main exporting competitors in Blood, antisera, vaccines, toxins and cultures were:

In 2018, United States's main importing competitors in Blood, antisera, vaccines, toxins and cultures were:

Explore Visualizations

Tariffs by Country

#permalink to section

In 2017, the tariffs for Blood, antisera, vaccines, toxins and cultures in the imports of United States were of 0% around the world.

Explore Tariff Data